Skip to main content
. 2022 Mar 11;12:4270. doi: 10.1038/s41598-022-08026-1

Figure 2.

Figure 2

Graphic representation of patients’ follow-up, including the number of patients with different degrees of baseline parenchymal extension and patients with or without residual abnormalities at the two follow-up timepoints.